<?xml version="1.0" encoding="UTF-8"?>
<p>In brief, people with diabetes should ensure a healthy lifestyle, regular glucose monitoring, and adherence to pharmacotherapy during this pandemic. Although diabetes does not increase the risk of infection, it increases the risk for complications and death [
 <xref rid="CIT0074" ref-type="bibr">74</xref>, 
 <xref rid="CIT0106" ref-type="bibr">106</xref>]. Obesity, hypertension, and cardiovascular diseases are common comorbidities of diabetes and are all linked with adverse outcomes with COVID-19 [
 <xref rid="CIT0107" ref-type="bibr">107</xref>, 
 <xref rid="CIT0108" ref-type="bibr">108</xref>]. Maintaining good glycemic control improves outcomes [
 <xref rid="CIT0109" ref-type="bibr">109</xref>]. Specific therapies for SARS-CoV-2 may have therapeutic implications when used in people with diabetes, thus warranting their cautious use [
 <xref rid="CIT0103" ref-type="bibr">103</xref>].
</p>
